Effect of auristatin PHE on microtubule integrity and nuclear localization in Cryptococcus neoformans

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3802-3808

  Woyke, Tanja ^a,b   Roberson, Robert W ^a   Pettit, George R ^a   Winkelmann, Günther ^b   Pettit, Robin K ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AURISTATIN PE; NOCODAZOLE; OLIGOPEPTIDE; SOBLIDOTIN;

ARTICLE; BASIDIOMYCETES; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; DOSE TIME EFFECT RELATION; DRUG EFFECT; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; MICROTUBULE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; YEAST; DOSE RESPONSE;

CRYPTOCOCCUS NEOFORMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; MICROTUBULES; NOCODAZOLE; OLIGOPEPTIDES;

EID: 0036896593     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3802-3808.2002     Document Type: Article

References (50)

1. Adames, N. R., and J. A. Cooper. 2000. Microtubule interactions with the cell cortex causing nuclear movements in Saccharomyces cerevisiae. J. Cell Biol. 149:863-874.
2. Agard, D. A., Y. Hiraoka, P. Shaw, and J. W. Sedat. 1989. Fluorescence microscopy in three dimensions. Methods Cell Biol. 30:353-377.
3. Amberg, D. C. 1998. Three-dimensional imaging of the yeast actin cytoskeleton through the budding cell cycle. Mol. Biol. Cell 9:3259-3262.
4. Botstein, D., D. Amberg, J. Mulholland, T. Huffaker, A. Adams, D. Drubin, and T. Stearns. 1997. The yeast cytoskeleton, p. 1-90. In J. R. Pringle, J. R. Broach, and E. W. Jones (ed.), The Molecular and Cellular Biology of the Yeast Saccharomyces. Cell Cycle and Cell Biology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
5. Busse, O. 1894. Ueber parasitaere Zelleinschluesse und ihre Zuechtung. Zentbl. Bakteriol. 16:175-180.
6. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus Neoformans. ASM Press, Washington, D.C.
7. Cruz, M. C., and T. Edlind. 1997. β-Tubulin genes and the basis for benzimidazole sensitivity of the opportunistic fungus Cryptococcus neoformans. Microbiology 143:2003-2008.
8. Davidse, L. C., and W. Flach. 1977. Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans. J. Cell Biol. 72:174-193.
9. Dayhoff, M. O. 1978. Atlas of Protein Sequence and Structure, vol. 5, suppl. 3. National Biomedical Research Foundation, Washington, D.C.
10. De Brabander, M. J., R. M. Van de Veire, F. E. Aerts, M. Borgers, and P. A. Janssen. 1976. The effects of methyl(5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl) carbamate, (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Res. 36:905-916.
11. de Gans, J., P. Portegies, G. Tiessens, J. K. Eeftinck Schattenkerk, C. J. van Boxtel, R. J. van Ketel, and J. Stam. 1992. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 6:185-190.
12. Fujimura, M., K. Oeda, H. Inoue, and T. Kato. 1992. A single amino-acid substitution in the beta-tubulin gene of Neurospora confers both carbendazim resistance and diethofencarb sensitivity. Curr. Genet. 21:399-404.
13. Hasek, J., J. Svobodova, and E. Streiblova. 1986. Immunofluorescence of the microtubular skeleton in growing and drug-treated yeast protoplasts. Eur. J. Cell Biol. 41:150-156.
14. Hoebeke, J., G. Van Nijen, and M. De Brabander. 1976. Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. Biochem. Biophys. Res. Commun. 69:319-324.
15. Hogan, L. H., B. S. Klein, and S. M. Levitz. 1996. Virulence factors of medically important fungi. Clin. Microbiol. Rev. 9:469-488.
16. Huffaker, T. C., J. H. Thomas, and D. Botstein. 1988. Diverse effects of beta-tubulin mutations on microtubule formation and function. J. Cell Biol. 106:1997-2010.
17. Jacobs, C. W., A. E. Adams, P. J. Szaniszlo, and J. R. Pringle. 1988. Functions of microtubules in the Saccharomyces cerevisiae cell cycle. J. Cell Biol. 107:1409-1426.
18. Joseph-Horne, T., D. Hollomon, R. S. Loeffler, and S. L. Kelly. 1995. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob. Agents Chemother. 39:1526-1529.
19. Jung, M. K., I. B. Wilder, and B. R. Oakley. 1992. Amino acid alterations in the benA (beta-tubulin) gene of Aspergillus nidulans that confer benomyl resistance. Cell Motil. Cytoskeleton 22:170-174.
20. Kelly, S. L., D. C. Lamb, M. Taylor, A. J. Corran, B. C. Baldwin, and W. G. Powderly. 1994. Resistance to amphotericin B associated with defective sterol δ 8→7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 122:39-42.
21. Kilmartin, J. V. 1981. Purification of yeast tubulin by self-assembly in vitro. Biochemistry 20:3629-3633.
22. King, S. M., and J. S. Hyams. 1982. The mitotic spindle of Saccharomyces cerevisiae: Assembly, structure and function. Micron 13:93-117.
23. Kopecka, M., M. Gabriel, K. Takeo, M. Yamaguchi, A. Svoboda, M. Ohkusu, K. Hata, and S. Yoshida. 2001. Microtubules and actin cytoskeleton in Cryptococcus neoformans compared with ascomycetous budding and fission yeasts. Eur. J. Cell Biol. 80:303-311.
24. Lee, J. C., D. J. Field, and L. L. Lee. 1980. Effects of nocodazole on structures of calf brain tubulin. Biochemistry 19:6209-6215.
25. Li, J., S. K. Katiyar, and T. D. Edlind. 1996. Site-directed mutagenesis of Saccharomyces cerevisiae beta-tubulin: Interaction between residue 167 and benzimidazole compounds. FEBS Lett. 385:7-10.
26. McCully, E. K., and C. F. Robinow. 1972. Mitosis in heterobasidiomycetous yeasts. I. Leucosporidium scottii (Candida scottii). J. Cell Sci. 10:857-881.
27. McCully, E. K., and C. F. Robinow. 1972. Mitosis in heterobasidiomycetous yeasts. II. Rhodosporidium sp. (Rhodotorula glutinis) and Aessosporon salmonicolor (Sporobolomyces salmonicolor). J. Cell Sci. 11:1-31.
28. McNally, J. G., T. Karpova, J. Cooper, and J. A. Conchello. July 1999. Three-dimensional imaging by deconvolution microscopy. Methods 19:373-385.
29. Meunier, F. 1991. Fungal infections in cancer patients. Cancer Investig. 9:151-158.
30. Mineyuki, Y., and M. Furuya. 1985. Involvement of microtubules on nuclear positioning during apical growth in Adiantum protonemata. Plant Cell Physiol. 26:627-634.
31. Mochizuki, T. 1998. Three-dimensional reconstruction of mitotic cells of Cryptococcus neoformans based on serial section electron microscopy. Nippon Ishinkin Gakkai Zasshi 39:123-127. (In Japanese.)
32. Mochizuki, T., S. Tanaka, and S. Watanabe. 1987. Ultrastructure of the mitotic apparatus in Cryptococcus neoformans. J. Med. Vet. Mycol. 25:223-233.
33. National Committee for Clinical Laboratory Standards. 1997. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
34. Oakley, B. R., and N. R. Morris. 1981. A beta-tubulin mutation in Aspergillus nidulans that blocks microtubule function without blocking assembly. Cell 24:837-845.
35. Orbach, M. J., E. B. Porro, and C. Yanofsky. 1986. Cloning and characterization of the gene for beta-tubulin from a benomyl-resistant mutant of Neurospora crassa and its use as a dominant selectable marker. Mol. Cell. Biol. 6:2452-2461.
36. Pettit, G. R. 1997. The dolastatins. Fortschr. Chem. Org. Naturst. 70:1-79.
37. Pettit, G. R., J. K. Srirangam, J. Barkoczy, M. D. Williams, M. R. Boyd, E. Hamel, R. K. Pettit, F. Hogan, R. Bai, J. C. Chapuis, S. C. McAllister, and J. M. Schmidt. 1998. Antineoplastic agents 365. Dolastatin 10 SAR probes. Anticancer Drug Des. 13:243-277.
38. Pettit, G. R., and J. K. Srirangam. July 1998. U.S. patent 5,780,588.
39. Pettit, R. K., G. R. Pettit, and K. C. Hazen. 1998. Specific activities of dolastatin 10 and peptide derivatives against Cryptococcus neoformans. Antimicrob. Agents Chemother. 42:2961-2965.
40. Pringle, J. R., A. E. Adams, D. G. Drubin, and B. K. Haarer. 1991. Immunofluorescence methods for yeast. Methods Enzymol. 194:565-602.
41. Roberson, R. W., B. Tucker, and G. R. Pettit. 1998. Microtubule depolymerization in Uromyces appendiculatus by three new antineoplastic drugs: Combretastatin A-4, dolastatin 10 and halichondrin B. Mycol. Res. 102:378-382.
42. Samonis, G., and D. Bafaloukos. 1992. Fungal infections in cancer patients: an escalating problem. In Vivo 6:183-193.
43. Scalettar, B. A., J. R. Swedlow, J. W. Sedat, and D. A. Agard. 1996. Dispersion, aberration and deconvolution in multi-wavelength fluorescence images. J. Microsc. 182:50-60.
44. Schulze, E., and M. Kirschner. 1987. Dynamic and stable populations of microtubules in cells. J. Cell Biol. 104:277-288.
45. Taylor, J. W., and K. Wells. 1979. A light and electron microscopic study of mitosis in Bullera alba and the histochemistry of some cytoplasmic substances. Protoplasma 98:31-62.
46. Thomas, J. H., N. F. Neff, and D. Botstein. 1985. Isolation and characterization of mutations in the beta-tubulin gene of Saccharomyces cerevisiae. Genetics 111:715-734.
47. Toda, T., K. Umesono, A. Hirata, and M. Yanagida. 1983. Cold-sensitive nuclear division arrest mutants of the fission yeast Schizosaccharomyces pombe. J. Mol. Biol. 168:251-270.
48. Umesono, K., T. Toda, S. Hayashi, and M. Yanagida. 1983. Cell division cycle genes nda2 and nda3 of the fission yeast Schizosaccharomyces pombe control microtubular organization and sensitivity to anti-mitotic benzimidazole compounds. J. Mol. Biol. 168:271-284.
49. van der Horst, C. M., M. S. Saag, G. A. Cloud, R. J. Hamill, J. R. Graybill, J. D. Sobel, P. C. Johnson, C. U. Tuazon, T. Kerkering, B. L. Moskovitz, W. G. Powderly, W. E. Dismukes, et al. 1997. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 337:15-21.
50. Woyke, T., G. R. Pettit, G. Winkelmann, and R. K. Pettit. 2001. In vitro activities and postantifungal effects of the potent dolastatin 10 derivative auristatin PHE. Antimicrob. Agents Chemother. 45:3580-3584.